Caption Management’s Gilead Sciences GILD Stock Holding History

Caption Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.6M	Buy	+100,000	New	+$13.2M	0.06%	338
2025 Q4	–	Sell	-49,900	Closed	-$6.06M	–	1761
2025 Q3	$5.54M	Sell	49,900 -98,700	-66%	-$11.2M	0.04%	456
2025 Q2	$16.5M	Buy	+148,600	New	+$15.8M	0.18%	112
2025 Q1	–	Sell	-20,000	Closed	-$2.06M	–	1712
2024 Q4	$1.85M	Buy	+20,000	New	+$1.8M	0.02%	718
2023 Q4	–	Sell	-7,500	Closed	-$584K	–	1459
2023 Q3	$562K	Buy	7,500 +2,000	+36%	+$154K	0.01%	909
2023 Q2	$424K	Sell	5,500 -1,825	-25%	-$146K	0.01%	848
2023 Q1	$608K	Buy	+7,325	New	+$607K	0.01%	751
2021 Q3	–	Sell	-130,000	Closed	-$9.13M	–	1610
2021 Q2	$8.95M	Buy	+130,000	New	+$8.68M	0.12%	223
2020 Q1	–	Sell	-20,000	Closed	-$1.3M	–	934
2019 Q4	$1.3M	Hold	20,000	–	–	0.04%	445
2019 Q3	$1.27M	Buy	+20,000	New	+$1.31M	0.07%	333

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caption Management's GILD Position: Q2 2026 in Review

Caption Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 100,000 shares worth $12.6M. The stake represents 0.06% of the portfolio and ranks #338 among its holdings. This is a return to the name: Caption Management previously reported a position in GILD as recently as Q3 2025.

Caption Management first reported a position in GILD in Q3 2019 and has held it in 10 quarters since. The position peaked at $16.5M in Q2 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Caption Management held 100,000 shares of Gilead Sciences worth $12.6M as of Q2 2026.
Gilead Sciences was a new Caption Management position in Q2 2026.
Gilead Sciences made up 0.06% of Caption Management's portfolio in Q2 2026, its #338 holding.
Caption Management first reported a position in Gilead Sciences in Q3 2019 and has held it in 10 quarters since.
Caption Management's Gilead Sciences position peaked at $16.5M in Q2 2025.
2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.